Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4114409

NC(=O)c1nc(-c2ccccc2)ns1.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 9/20 0.46
ADORA2A P29274 1/20 0.46
ADORA2B P29275 1/20 0.46
ADORA1 P30542 1/20 0.46
SMN1; SMN2 Q16637 6/20 0.45
NPC1 O15118 6/20 0.45
RAB9A P51151 6/20 0.45
LMNA P02545 4/20 0.45
TP53 P04637 1/20 0.45
POLB P06746 1/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
HTT P42858 2/20 0.42
MAPT P10636 1/20 0.42
GFER P55789 1/20 0.42
CASP3 P42574 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3088205 0.91 ADORA3 (0.55) ADORA3ADORA2AADORA2BADORA1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL4114413 0.82 ADORA3 (0.72) ADORA3ADORA2AADORA2BADORA1SMN1; SMN2
SCHEMBL16238753 0.78 LMNA (0.48) SMN1; SMN2NPC1RAB9ALMNATP53
SCHEMBL17960860 0.77 ADORA3 (0.54) ADORA3ADORA2AADORA2BADORA1SMN1; SMN2
SCHEMBL9108540 0.76 HSD17B1 (0.46) ADORA3ADORA2AADORA2BADORA1SMN1; SMN2
SCHEMBL11883602 0.75 CYP19A1 (0.58) SMN1; SMN2LMNATP53HTTMAPT
SCHEMBL2564546 0.74 ADORA3 (0.55) ADORA3ADORA2AADORA2BADORA1SMN1; SMN2
SCHEMBL9107820 0.72 ADORA3 (0.58) ADORA3SMN1; SMN2TP53KMT2AMAPT
Trifluoroacetic Acid SCHEMBL29379876 0.72 HDAC6 (0.52) ADORA2AL3MBTL1HDAC4HDAC1HDAC6
Trifluoroacetic Acid SCHEMBL6926839 0.71 MKNK1 (0.59) SMN1; SMN2NPC1RAB9ALMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090062294-A1 HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE JANSSEN PHARMACEUTICA NV (BE) 2009-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062294-A1 HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, GPR119 ADORA3 766/4885ADORA2A 484/4885ADORA2B 436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.